Yilong Cheng Selected Research

Yilong Cheng Research Topics

Disease

8	Neoplasms (Cancer) 01/2021 - 12/2013
4	Wounds and Injuries (Trauma) 04/2024 - 11/2021
4	Osteosarcoma (Osteogenic Sarcoma) 02/2017 - 10/2014
3	Inflammation (Inflammations) 04/2024 - 11/2021
3	Hemolysis 10/2023 - 01/2019
3	Tissue Adhesions 01/2023 - 10/2019
3	Fatigue 01/2023 - 10/2020
1	Stomach Ulcer (Gastric Ulcer) 04/2024
1	Ulcer 04/2024
1	Bone Resorption 03/2024
1	Periodontal Pocket (Periodontal Pockets) 03/2024
1	Periodontitis 03/2024
1	Hernia (Hernias) 06/2023
1	Spinal Injuries (Spinal Injury) 05/2023
1	Spinal Cord Injuries (Spinal Cord Injury) 05/2023
1	Hemorrhage 01/2023
1	Chronic Periodontitis 01/2022
1	Bacterial Infections (Bacterial Infection) 11/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2021
1	Persistent Infection 11/2021
1	Infections 10/2021
1	COVID-19 10/2021
1	Residual Neoplasm 01/2021
1	Adenocarcinoma of Lung 10/2020
1	Lung Neoplasms (Lung Cancer) 10/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Rupture 01/2019
1	Kidney Diseases (Kidney Disease) 12/2018
1	Hematologic Neoplasms (Hematological Malignancy) 01/2018
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Myocardial Infarction 04/2014
1	Infarction (Infarctions) 04/2014
1	Liver Neoplasms (Liver Cancer) 12/2013
1	Hepatocellular Carcinoma (Hepatoma) 08/2013
1	Dehydration (Water Stress) 07/2012

Drug/Important Bio-Agent (IBA)

16	HydrogelsIBA 04/2024 - 12/2013
4	PolymersIBA 05/2023 - 08/2013
4	Peptides (Polypeptides)IBA 01/2019 - 07/2012
4	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2015 - 08/2013
3	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 08/2013
3	polyethylene glycol-poly(lactide-co-glycolide)IBA 12/2015 - 10/2014
2	AcidsIBA 04/2024 - 12/2018
2	Therapeutic UsesIBA 03/2024 - 10/2023
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2018
2	Ethylene Glycol (Monoethylene Glycol)IBA 01/2021 - 07/2012
1	SolutionsIBA 04/2024
1	Acetic Acid (Vinegar)FDA LinkGeneric 04/2024
1	Pepsin A (Pepsin)IBA 04/2024
1	Photosensitizing Agents (Photosensitizers)IBA 03/2024
1	16S Ribosomal RNAIBA 03/2024
1	ViologensIBA 03/2024
1	Sincalide FDA Link 10/2023
1	Oxidants (Oxidizing Agents)IBA 11/2021
1	Polyurethanes (Polyurethane)IBA 11/2021
1	Tannic Acid FDA Link 11/2021
1	AntioxidantsIBA 11/2021
1	imidazolidinyl ureaIBA 11/2021
1	SARS-CoV-2 spike proteinIBA 10/2021
1	Angiotensin-Converting Enzyme 2IBA 10/2021
1	Disinfectants (Biocides)IBA 10/2021
1	polyaminopropylbiguanide (PAPB)IBA 01/2021
1	poly(lactide) (polylactic acid)IBA 01/2021
1	polycationsIBA 11/2020
1	Elastomers (Elastomer)IBA 10/2020
1	ResveratrolIBA 10/2020
1	SeprafilmIBA 07/2020
1	ProdrugsIBA 01/2020
1	PlatinumIBA 01/2020
1	GelatinIBA 10/2019
1	catechol (pyrocatechol)IBA 10/2019
1	MethacrylatesIBA 10/2019
1	MicellesIBA 10/2019
1	Drug CarriersIBA 01/2019
1	Monoclonal AntibodiesIBA 01/2018
1	Chimeric Antigen ReceptorsIBA 01/2018
1	fosbretabulin (combretastatin A4)IBA 02/2017
1	Docetaxel (Taxotere)FDA Link 02/2017
1	Cisplatin (Platino)FDA LinkGeneric 12/2015
1	Methotrexate (Mexate)FDA LinkGeneric 12/2015
1	PolylysineIBA 10/2014
1	PolyethyleneimineIBA 10/2014
1	Biocompatible Materials (Biomaterials)IBA 04/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2013
1	Polymethyl Methacrylate (Sol)IBA 07/2012

Therapy/Procedure

5	Injections 01/2022 - 12/2013
3	Drug Therapy (Chemotherapy) 01/2020 - 08/2013
3	Therapeutics 10/2019 - 04/2014
1	Endoscopes 04/2024
1	Photochemotherapy (Photodynamic Therapy) 03/2024
1	Periodontal Dressings 10/2023
1	Immunotherapy 01/2018
1	Microspheres (Microsphere) 02/2017
1	Subcutaneous Injections 10/2014